Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
PT-141 Key Research Facts: Rapid Reference 10 Things Researchers Should Know About PT-141 PT-141 Peptide is the only melanocortin receptor agonist with FDA approval for sexual dysfunction (in women, as Vyleesi) It acts centrally on the brain, not peripherally on blood vessels making it mechanistically distinct from all PDE-5 inhibitors Its primary targets are MC3R and MC4R in the hypothalamus Clinical trials involved 1,200+ premenopausal women, providing a robust safety and efficacy dataset The most common side effect is transient nausea, observed in approximately 40% of subjects PT-141 produces a temporary, dose-dependent increase in blood pressure (~6 mmHg systolic) Effects onset within 4560 minutes and can persist 1224 hours The compound was derived from Melanotan II, with the pigmentation mechanism removed PT-141 has no significant interaction with the PDE-5 enzyme it works through an entirely different pathway Research-grade PT-141 is available as a lyophilized powder requiring reconstitution with bacteriostatic water Conclusion: PT-141 (Bremelanotide) is not a peripheral compound or a trend-driven research curiosity
Specifications For research use only
578 Cocoa Flavanols Flavanols are a type of polyphenol found in cocoa, as well as fruits, vegetables, and tea
Tried Miradry on My Armpits and Its Working - Highly satisfied patient Listen to Sarahs testimonial to understand how miraDry can save your day and bring you relief and comfort which may have been eluding you for years due to underarm sweating and odor
Taking extra medication only increases the concentration of the drug to toxic levels, which will likely make you too ill to maintain the healthy eating and exercise habits necessary for long-term success
Its stability in the gastric acid environment is a natural property, not an engineered formulation characteristic
